Progress in Endovascular Treatment for Peripheral Arterial Disease_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

包俊敏

Corresponding author：

Keywords：

周围动脉疾病; 腔内治疗; 适应证; 经皮血管腔内成形术; 支架; 重症肢体缺血

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 包俊敏. Progress in Endovascular Treatment for Peripheral Arterial Disease. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2010, 17(7): 645-648. doi: Copy

1.	Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASCⅡ) [J]. J Vasc Surg, 2007; 45 Suppl S: S5S67.
2.	Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review [J]. Cardiovasc Intervent Radiol, 2008; 31(4): 687697.
3.	Rückert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study [J]. J Vasc Surg, 2009; 49(5): 12031209.
4.	McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol selfexpanding stent graft vs prosthetic femoralpopliteal bypass in the treatment of superficial femoral artery occlusive disease [J]. J Vasc Surg, 2009; 49(1): 109116.
5.	Faglia E, Clerici G, Clerissi J, et al. Longterm prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study [J]. Diabetes Care, 2009; 32(5): 822827.
6.	Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease [J]. Nephrol Dial Transplant, 2007; 22(4): 11441149.
7.	Chew DK, Conte MS, Donaldson MC, et al. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction [J]. J Vasc Surg, 2001; 33(2): 259265.
8.	Faries PL, Arota S, Pomposelli FB Jr, et al. The use of arm vein in lowerextremity revascularization: results of 520 procedures performed in eight years [J]. J Vasc Surg, 2000; 31(1 Pt 1): 5059.
9.	Halloran BG, Lilly MP, Cohn EJ, et al. Tibial bypass using complex autologous conduit: patency and limb salvage [J]. Ann Vasc Surg, 2001; 15(6): 634643.
10.	Rabellino M, Zander T, Baldi S, et al. Clinical followup in endovascular treatment for TASC CD lesions in femoropopliteal segment [J]. Catheter Cardiovasc Interv, 2009; 73 (5): 701705.
11.	Donas KP, Schwindt A, Schnefeld T, et al. Belowknee bare nitinol stent placement in highrisk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice [J]. Eur J Vasc Endovasc Surg, 2009; 37(6): 688693.
12.	Ansel GM, Sample NS, Botti III CF Jr, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia [J]. Catheter Cardiovasc Interv, 2004; 61(1): 14.
13.	Engelke C, Sandhu C, Morgan RA, et al. Using 6mm Cutting Balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results [J]. AJR Am J Roentgenol, 2002; 179(3): 619623.
14.	Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection [J]. J Endovasc Ther, 2006; 13(5): 592602.
15.	McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions [J]. Ann Surg, 2008; 248(4): 519528.
16.	Saxon RR, Coffman JM, Gooding JM, et al. Longterm results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial [J]. J Vasc Interv Radiol, 2003; 14(3): 303311.
17.	Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft [J]. J Endovasc Ther, 2003; 10(3): 619628.
18.	Farraj N, Srivastava A, Pershad A. Oneyear outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft [J]. J Invasive Cardiol, 2009; 21(6): 278281.
19.	Deutschmann HA, Schedlbauer P, Bérczi V, et al. Placement of Hemobahn stentgrafts in femoropopliteal arteries: early experience and midterm results in 18 patients [J]. J Vasc Interv Radiol, 2001; 12(8): 943950.
20.	Duda SH, Poerner TC, Wiesinger B, et al. Drugeluting stents: potential applications for peripheral arterial occlusive disease [J]. J Vasc Interv Radiol, 2003; 14(3): 291301.
21.	Duda SH, Bosiers M, Lammer J, et al. Sirolimuseluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial [J]. J Vasc Interv Radiol, 2005; 16(3): 331338.
22.	Minar E, Schillinger M. New stents for SFA [J]. J Cardiovasc Surg (Torino), 2009; 50(5): 635645.
23.	Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting [J]. Circulation, 2007; 115(21): 27452749.
24.	Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimuseluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6month angiographic results from a nonrandomized prospective singlecenter study [J]. J Endovasc Ther, 2005; 12(6): 685695.
25.	Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimuseluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1year angiographic and clinical benefit [J]. J Endovasc Ther, 2007; 14(2): 241250.
26.	Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues [J]. J Endovasc Ther, 2009; 16 Suppl Ⅰ: Ⅰ153 Ⅰ162.
27.	Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4F selfexpanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia [J]. J Vasc Interv Radiol, 2007; 18(6): 703708.
28.	王玉琦, 史振宇. 我国血管外科的现状与展望 [J]. 中国普外基础与临床杂志, 2008; 15(6): 387389.

1. Norgren L, Hiatt WR, Dormandy JA, et al. Intersociety consensus for the management of peripheral arterial disease (TASCⅡ) [J]. J Vasc Surg, 2007; 45 Suppl S: S5S67.
2. Met R, Van Lienden KP, Koelemay MJ, et al. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review [J]. Cardiovasc Intervent Radiol, 2008; 31(4): 687697.
3. Rückert RI, Tsilimparis N, Lobenstein B, et al. Midterm results of a precuffed expanded polytetrafluoroethylene graft for above knee femoropopliteal bypass in a multicenter study [J]. J Vasc Surg, 2009; 49(5): 12031209.
4. McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol selfexpanding stent graft vs prosthetic femoralpopliteal bypass in the treatment of superficial femoral artery occlusive disease [J]. J Vasc Surg, 2009; 49(1): 109116.
5. Faglia E, Clerici G, Clerissi J, et al. Longterm prognosis of diabetic patients with critical limb ischemia: a populationbased cohort study [J]. Diabetes Care, 2009; 32(5): 822827.
6. Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease [J]. Nephrol Dial Transplant, 2007; 22(4): 11441149.
7. Chew DK, Conte MS, Donaldson MC, et al. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction [J]. J Vasc Surg, 2001; 33(2): 259265.
8. Faries PL, Arota S, Pomposelli FB Jr, et al. The use of arm vein in lowerextremity revascularization: results of 520 procedures performed in eight years [J]. J Vasc Surg, 2000; 31(1 Pt 1): 5059.
9. Halloran BG, Lilly MP, Cohn EJ, et al. Tibial bypass using complex autologous conduit: patency and limb salvage [J]. Ann Vasc Surg, 2001; 15(6): 634643.
10. Rabellino M, Zander T, Baldi S, et al. Clinical followup in endovascular treatment for TASC CD lesions in femoropopliteal segment [J]. Catheter Cardiovasc Interv, 2009; 73 (5): 701705.
11. Donas KP, Schwindt A, Schnefeld T, et al. Belowknee bare nitinol stent placement in highrisk patients with critical limb ischaemia and unlimited supragenicular inflow as treatment of choice [J]. Eur J Vasc Endovasc Surg, 2009; 37(6): 688693.
12. Ansel GM, Sample NS, Botti III CF Jr, et al. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia [J]. Catheter Cardiovasc Interv, 2004; 61(1): 14.
13. Engelke C, Sandhu C, Morgan RA, et al. Using 6mm Cutting Balloon angioplasty in patients with resistant peripheral artery stenosis: preliminary results [J]. AJR Am J Roentgenol, 2002; 179(3): 619623.
14. Ramaiah V, Gammon R, Kiesz S, et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection [J]. J Endovasc Ther, 2006; 13(5): 592602.
15. McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions [J]. Ann Surg, 2008; 248(4): 519528.
16. Saxon RR, Coffman JM, Gooding JM, et al. Longterm results of ePTFE stent graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial [J]. J Vasc Interv Radiol, 2003; 14(3): 303311.
17. Bray PJ, Robson WJ, Bray AE. Percutaneous treatment of long superficial femoral artery occlusive disease: efficacy of the Hemobahn stent graft [J]. J Endovasc Ther, 2003; 10(3): 619628.
18. Farraj N, Srivastava A, Pershad A. Oneyear outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft [J]. J Invasive Cardiol, 2009; 21(6): 278281.
19. Deutschmann HA, Schedlbauer P, Bérczi V, et al. Placement of Hemobahn stentgrafts in femoropopliteal arteries: early experience and midterm results in 18 patients [J]. J Vasc Interv Radiol, 2001; 12(8): 943950.
20. Duda SH, Poerner TC, Wiesinger B, et al. Drugeluting stents: potential applications for peripheral arterial occlusive disease [J]. J Vasc Interv Radiol, 2003; 14(3): 291301.
21. Duda SH, Bosiers M, Lammer J, et al. Sirolimuseluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO Ⅱ trial [J]. J Vasc Interv Radiol, 2005; 16(3): 331338.
22. Minar E, Schillinger M. New stents for SFA [J]. J Cardiovasc Surg (Torino), 2009; 50(5): 635645.
23. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting [J]. Circulation, 2007; 115(21): 27452749.
24. Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimuseluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6month angiographic results from a nonrandomized prospective singlecenter study [J]. J Endovasc Ther, 2005; 12(6): 685695.
25. Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimuseluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1year angiographic and clinical benefit [J]. J Endovasc Ther, 2007; 14(2): 241250.
26. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues [J]. J Endovasc Ther, 2009; 16 Suppl Ⅰ: Ⅰ153 Ⅰ162.
27. Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4F selfexpanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia [J]. J Vasc Interv Radiol, 2007; 18(6): 703708.
28. 王玉琦, 史振宇. 我国血管外科的现状与展望 [J]. 中国普外基础与临床杂志, 2008; 15(6): 387389.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Progress in Endovascular Treatment for Peripheral Arterial Disease

Abstract Full text Figures/Tables Video References Cited by

Format

Content